Moderna Hails Diversity Of Covid Trial Participants
Umer Jamshaid Published October 22, 2020 | 11:00 PM
Washington, (UrduPoint / Pakistan Point News - 22nd Oct, 2020 ) :Biotech firm Moderna said Thursday that it had successfully recruited ethnic minorities, older people and those with underlying health issues for its Covid-19 vaccines trial, after it pushed to enrol groups most vulnerable to the virus.
Moderna said it had now signed up all 30,000 participants for the phase-3 trial, and more than 25,000 of them had already received a second dose of the vaccine, four weeks after the first.
The firm said it was working "to develop a vaccine for everyone, including communities that have historically been under-represented in clinical research and are disproportionately impacted by Covid-19." More than 7,000 people taking part in the trial are over 65, and more than 5,000 under 65 have high-risk diseases such as diabetes, severe obesity and cardiac disease.
The firm said more than 11,000 are "from communities of color, representing 37 percent of the study population and similar to the diversity of the US at large" -- 6,000 are Hispanic or Latino, and more than 3,000 are African-American.
Massachusetts-based Moderna is one of the few companies to have launched a large-scale clinical trial less than 10 months after the genetic sequencing of the novel coronavirus was established.
Some Chinese, Russian and other Western projects are also in advanced tests, including US firm Pfizer.
Moderna hopes to have sufficient results by the end of November and to then file an emergency authorization request with the US food and Drug Administration (FDA).
The company has already said it was aiming to file for authorization soon after November 25, with Pfizer at the third week of November.
The US government says it will distribute the first doses immediately after authorization free of charge.
Related Topics
Recent Stories
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
Woman stabbed in Israel, attacker killed: police
More Stories From Miscellaneous
-
Modern Education Techniques: A pathway to achieve economic development
21 hours ago -
Kite Flying: From cultural festival to deadly sport
21 hours ago -
PDMA predicts gusty wind, rain with thunder, hails
4 days ago -
Iranian president Raisi given guard of honour at PM House
5 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
5 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
6 days ago
-
Cattle farming vital to alleviate poverty in rural areas
6 days ago -
Pakistan: A land of tourism, archeological wonders
6 days ago -
Transforming education sector: from job hunters to job creators
8 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
12 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
13 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
13 days ago